InSightec ExAblate 2000 Approved For Uterine Fibroids; 3-Year Study Required
This article was originally published in The Gray Sheet
Executive Summary
FDA approval conditions for InSightec's ExAblate 2000 uterine fibroid ultrasound treatment respond to advisory panel concerns about short-term safety and efficacy data in the original PMA submission